Biomarker Discovery Demand Ocean Ridge Biosciences specializes in RNA and protein biomarker discovery services, including circulating small RNA, exosome characterization, microbiome sequencing, multiplex immunoassays, and DNA polymorphism analysis, signaling strong potential for CRO partnerships targeting pharma and biotech clients prioritizing biomarker-driven drug development and companion diagnostics.

Companion Diagnostics Focus ORB aims to develop multi-analyte companion diagnostic tests alongside client drugs and recently partnered with Boca Biolistics Clinical Reference Laboratory to validate a 35-plex immunoassay for companion diagnostics discovery, presenting opportunities to sell assay development, validation, and clinical integration services to pharma companies pursuing precision medicine.

Academic & Industry Collaborations With collaborations at Emory University, Roosevelt Hospital, and the University of Miami and publications cited in over 90 articles, ORB has established credibility and networks that can be leveraged to win sponsored research, co-development, and sponsored biomarker discovery projects with academic and biotech partners.

Clinical Lab Capabilities ORB’s pipeline includes CAP-accredited lab capabilities through partner Boca Biolistics for validated multiplex immunoassays, indicating a robust path to scale contract testing, assay validation, and regulated diagnostic development services for clients seeking compliant, clinically deployable assays.

South Florida Life Science Synergy Headquartered in Deerfield Beach within a growing South Florida life science cluster, ORB is poised to capitalize on regional pharma/biotech diversification, access to skilled talent, and potential co-location or regional partnership opportunities with nearby contractors and academic hubs.